What is PharmaBioServ?
PharmaBioServ operates as a specialized consulting firm, offering critical compliance and technology transfer services tailored for the pharmaceutical, biotechnology, medical device, and chemical manufacturing sectors. The company's expertise spans regulatory compliance, validation, technology transfer, engineering, project management, and process support across key global markets including Puerto Rico, the United States, Europe, and Brazil. PharmaBioServ also provides valuable technical training and seminars, reaching its audience through industry trade shows, professional conventions, and specialized publications.
How much funding has PharmaBioServ raised?
PharmaBioServ has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in PharmaBioServ
PPP
Public-Private Partnership
What's next for PharmaBioServ?
The recent major strategic investment signals a period of accelerated growth and potential expansion for PharmaBioServ. This capital infusion is likely to bolster its service offerings, enhance its technological capabilities, and potentially broaden its geographical reach. The company's focus on compliance and technology transfer within highly regulated industries positions it for continued relevance and demand, especially as global markets navigate complex regulatory environments. This strategic backing suggests PharmaBioServ is poised to further solidify its market position and pursue new opportunities in its core sectors.
See full PharmaBioServ company page
